#bright_minds_biosciences a #biotechnology_company focused on developing novel drugs for the targeted treatment of #neuropsychiatric_disorders, #epilepsy, and pain, today announced that Ian McDonald, Chief Executive Officer, Dr. Revati Shreeniwas, Chief Medical Officer, Professor John McCorvy, PhD, Senior Advisor, and other key speakers will host a symposium on the recent therapeutic developments within the Dravet Syndrome landscape. https://bit.ly/3wL3n38
![image](https://buzzbiipull.b-cdn.net/upload/photos/2022/05/Ov7So2cYiBilwjqASiag_23_f4f097176a7d58e7805e4347e6172174_image.jpg)